ArticleBMC pulmonary medicine2025
Association between the red cell distribution width-to-platelet ratio and 30-day all-cause mortality among patients with acute respiratory failure: a retrospective analysis of the MIMIC-IV database.
Article in BMC pulmonary medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association between albumin-bilirubin score and all-cause mortality in patients with acute respiratory failure: a cohort study based on the MIMIC-IV database.Journal of thoracic disease · 2026Article
- Associations of Red Blood Cell Distribution Width-Derived Indicators and Their Longitudinal Dynamic Trajectories With Mortality Risk in Critically Ill Patients With Pulmonary Hypertension.Pulmonary circulation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThe importance of the red cell distribution width (RDW)-to-platelet ratio (RPR) in clinical practice has been described in various diseases. However, the prognostic importance of the RPR in patients with acute respiratory failure (ARF) remains unclear. The aim of the present study was to investigate the association of the RPR with 30-day all-cause mortality among ARF patients in the intensive care unit (ICU).
methodsData were obtained from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database (version 3.1). The study population was divided into different groups based on RPR quartiles (Q1-Q4). The outcome of interest was all-cause mortality within 30 days. Cox proportional regression analysis was performed to determine the relationship between the RPR and 30-day mortality, and Kaplan‒Meier (K‒M) analysis was conducted to obtain survival curves. Additionally, restricted cubic spline (RCS) analysis was utilized to determine whether there was a nonlinear correlation between the RPR (as a continuous variable) and 30-day mortality in ARF patients. Subgroup analysis was subsequently performed to determine whether the association between the RPR and 30-day mortality in ARF patients was stable across the subgroups.
resultsA total of 10,912 ARF patients were enrolled in this study. The 30-day mortality rate was 27.2%. Cox proportional regression analysis revealed that an elevated RPR was associated with an increased risk of 30-day mortality in ARF patients. Furthermore, K‒M survival analyses revealed that patients with higher RPR levels demonstrated significantly higher all-cause mortality rates within 30 days of admission than patients with lower RPRs. The RCS model illustrated the linear relationship between a higher RPR and increased risk of mortality in this specific patient population. The final subgroup analysis indicated no significant interaction effect of the RPR in most of the subgroups.
conclusionsThis study demonstrated that RPR levels were significantly associated with short-term prognosis in patients with ARF and that a high RPR could serve as an independent predictor of all-cause mortality at 30 days in patients with ARF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.